Serum Institute of India Pvt. Ltd. is now the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.3 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by Serum Institute. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization, Geneva and are being used in around 170 countries across the globe in their national immunization programs, saving millions of lives throughout the world. Serum Institute of India is ranked as India's No. 1 biotechnology company, manufacturing highly specialized life saving biologicals like vaccines using cutting edge genetic and cell based technologies, antisera and other medical specialties. Serum Institute of India was founded in 1966 by Dr. Cyrus Poonawalla with the aim of manufacturing life-saving immuno-biologicals, which were in shortage in the country and imported at high prices. Thereafter, several life-saving biologicals were manufactured at prices affordable to the common man and in abundance, with the result that the country was made self-sufficient for Tetanus Anti-toxin and Anti-snake Venom serum, followed by DTP (Diphtheria, Tetanus and Pertussis) group of Vaccines and then later on MMR (Measles, Mumps and Rubella) group of vaccines. The Philanthropic philosophy of the company still not only exists but has been proliferated to bring down the prices of newer vaccines such as Hepatitis-B vaccine, Combination vaccine etc., so that not only Indian's, but the entire under-privileged children of the world are protected from birth onwards.
View Top Employees from Serum Institute of India Pvt. Ltd.Website | http://www.seruminstitute.com |
Revenue | $616.4 million |
Employees | 4,495 (2,862 on RocketReach) |
Founded | 1966 |
Address | 212/2 Hadapsar off Soli Poonawalla Rd, Pune, Maharashtra 411028, IN |
Phone | +91 20 2699 3900 |
Industry | Manufacturing, Biotechnology Research, Chemicals, Petrochemicals, Glass & Gases, Human Vaccines : Bacterial Vaccines, Viral Vaccines, Pharmaceutical, Recombinant and Combination Vaccines, Health Care, Polysaccharide Conjugate Vaccines, Influenza Vaccines, Antisera, Recombinant Products |
Web Rank | 2 Million |
Keywords | Vaccine Development |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 325 Companies, NAICS Code 541711 Companies, NAICS Code 325414 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Serum Institute of India Pvt. Ltd. employee's phone or email?
The Serum Institute of India Pvt. Ltd. annual revenue was $616.4 million in 2024.
2,862 people are employed at Serum Institute of India Pvt. Ltd..
Serum Institute of India Pvt. Ltd. is based in Pune, Maharashtra.
The NAICS codes for Serum Institute of India Pvt. Ltd. are [32541, 5417, 541, 54, 54171, 325, 541711, 325414, 32, 3254].
The SIC codes for Serum Institute of India Pvt. Ltd. are [28, 283].